Walvax Biotechnology Co.,Ltd. Fundamental Rankings

This page is comprehensive fundamental data for Walvax Biotechnology Co.,Ltd.. Fundamentals are ordered by how Walvax Biotechnology Co.,Ltd. ranks compared to other companies (ordered high to low). All money values are in CNY. All data is powered by Quandl.

Cite in Wikipedia:

Indicator Value n/price Rank Date Historic
Other receivables879,469,1240.038591072015-06-30historic
Goodwill950,720,6220.041711082015-06-30historic
Interests payable55,288,7960.002432102015-06-30historic
Other current liabilities21,751,6989.5E-42312015-06-30historic
Diluted eps-00.02502015-06-30historic
Long term equity investment468,472,6670.020552752015-06-30historic
Cash paid for other investing activities2,500,0001.1E-43232015-06-30historic
Interest receivable1,602,1647.0E-53392015-06-30historic
Minority interest415,167,0360.018223652015-06-30historic
Other payables489,293,0080.021473742015-06-30historic
Disposal of fixed assets and others920,6294.0E-54162015-06-30historic
Cash paid for other financing activities26,392,0000.001164412015-06-30historic
Deferred tax assets79,452,9860.003494612015-06-30historic
Non-operating loss3,451,9421.5E-44652015-06-30historic
Financial expenses63,536,6490.002794782015-06-30historic
Investment income from associate and joint venture-7,850,647-3.4E-45552015-06-30historic
Net cashflow from financing activities131,771,4890.005786082015-06-30historic
Short term borrowings865,000,0000.037956212015-06-30historic
Net cash flows from investing activities-195,221,782-0.008576432015-06-30historic
Total non-current assets4,135,773,4640.181466692015-06-30historic
Purchases of fixed assets and others111,933,4530.004917572015-06-30historic
Total liabilities3,106,181,3390.136297772015-06-30historic
Capital reserve1,659,854,9200.072837872015-06-30historic
Refunds of taxes186,6891.0E-57982015-06-30historic
Selling expenses73,686,4620.003238062015-06-30historic
Net change in cash-135,619,625-0.005958252015-06-30historic
Cash inflows from financing activities611,818,2000.026848682015-06-30historic
Intangible assets203,254,0820.008928972015-06-30historic
Notes receivable5,960,7782.6E-49752015-06-30historic
Total liabilities and equity6,314,875,7230.277079892015-06-30historic
Prepayment56,047,7230.0024610142015-06-30historic
Comprehensive income attributable to minority shareholders-19,460,531-8.5E-410202015-06-30historic
Other current assets3,025,4981.3E-410302015-06-30historic
Minority interests gain-19,460,531-8.5E-410322015-06-30historic
Cash paid for dividends, profits or interests37,654,7110.0016510702015-06-30historic
Fixed assets484,253,3560.0212510742015-06-30historic
Accounts payable209,606,8980.009210872015-06-30historic
Net cash and cash equivalents ending balance448,588,3600.0196811162015-06-30historic
Inventories173,965,1770.0076311872015-06-30historic
Operating profit-84,869,870-0.0037212082015-06-30historic
Total cost of goods sold494,249,3150.0216912172015-06-30historic
Cash paid for taxes42,946,1250.0018812202015-06-30historic
Total comprehensive income-86,585,455-0.003812342015-06-30historic
Net income-86,585,455-0.003812372015-06-30historic
Total profit-82,081,270-0.003612372015-06-30historic
Payroll payable4,423,5891.9E-412592015-06-30historic
Revenue413,747,3150.0181512842015-06-30historic
Cash outflows from operating activities415,367,5580.0182212912015-06-30historic
Cash inflows from operating activities343,198,2250.0150613022015-06-30historic